Baxter International, Inc. Receives Marketing Authorization in European Union for VEPACEL Pre-Pandemic Influenza Vaccine

VIENNA--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX) announced today that the European Commission (EC) has granted marketing authorization for VEPACEL in all European Union (EU) Member States, as well as Iceland, Liechtenstein and Norway.

MORE ON THIS TOPIC